Skip to main content

Partners Investment — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

79
Companies
$926.9M
Total invested
$16.6M
Avg. check
39
Industries
Biotechnology 10Medical 6Artificial Intelligence (AI) 5Pharmaceutical 4Health Care 4Information Technology 3+33 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 79
Dime Bio
March 2025

Dime Bio is a drug development company for novel dementia treatments.

Medical · Seongnam$8.2M Series A
Artist United
March 2025

Artist United is a data management platform targeting advertising services based on big data.

Ad Retargeting · Seoul$12.3M Post Ipo Equity
MediThinQ
March 2025

MediThinQ is a medical technology company that develops and manufactures the eyes up surgical display.

Manufacturing · Seongnam$8.5M Series B
JLT
February 2025

JLT is a company that offers factory automation equipment solutions.

Industrial Automation · Seongnam$16.1M Series B
Ubix Therapeutics
December 2024

Ubix Therapeutics is a research and development company that develops anti-cancer drugs.

Biotechnology · Seoul$17.7M Series C
Storelink
November 2024

Storelink is an open market optimization platform that analyzes and processes accurate online sales data.

Marketing · Seoul$2.9M Series C
Soft Berry
November 2024

Soft Berry is an electric vehicle charging platform.

Automotive · Jeju$9.3M Series A
Quad Miners
August 2024

Quad Miners creates the Network Blackbox, a solution that proactively detects and responds to cyber threats.

Cyber Security · Yeoksamdong$440K Grant
GeneCast
July 2024

GeneCast provides cancer screening, monitoring, precision care services.

Health Care · Songpadong$4.0M Series Unknown
Xpanner
June 2024

Xpanner(Builtworlds 2022 Top 50), digital contech site solution, bringing productivity improvement(15% average) through smart integration.

Construction · Seoul$10.8M Series B
DewCell
April 2024

DewCell develops artificial platelets through stem cell differentiation technology.

Biopharma · Seongnam$6.6M Series B
Drimaes
April 2024

Drimaes providers automotive software platform intended to offer in-vehicle infotainment services.

Automotive · Daegu$2.2M Corporate Round
XBoost
April 2024

XBoost develops AI agents for online marketplace sellers and brands to automate their growth and operations with breakthrough innovation.

Artificial Intelligence (AI) · Los Angeles$8.6M Series A
Artblood
April 2024

Artblood is a cell-based artificial blood production company.

Artificial Intelligence (AI) · Seocho$4.8M Series A
Surginex
March 2024

Surginex is a biological drug development company that offers molecular biology, genetics, physical, and chemical analysis services.

Biotechnology · Seocho$6.3M Series B
Dyne Medical Group
January 2024

Dyne Medical Group is a medical equipment manufacturer that provides endoscopy devices and AI solutions for urological surgery.

Artificial Intelligence (AI) · Gyeongju$7.5M Series B
Astrogen, inc.
January 2024

Astrogen, inc. develops small molecule therapies for neurological and rare diseases, including autism spectrum disorder (ASD).

Biotechnology · Daegu$9.3M Series C
Cytonus Therapeutics
November 2023

Cytonus Therapeutics focuses on developing novel therapeutic solutions using its proprietary drug delivery platform.

Artificial Intelligence (AI) · Carlsbad$11.7M Series A
Harbinger Health
September 2023

Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.

Artificial Intelligence (AI) · Cambridge$140.0M Series B
Endorobotics
August 2023

Endorobotics is a healthcare centre that offers endoscopic surgery services.

Health Care · Seoul$7.5M Series B
IMBiologics
July 2023

IMBiologics is a biotechnology company that develops immunomodulatory antibody drugs for physiological balance.

Biotechnology · Seongnam$15.6M Series B
AltPep
June 2023

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Biotechnology · Seattle$52.9M Series B
K-NETZ
May 2023

K-NETZ is an IT company that provides value-oriented R&D and possesses global technological competitiveness services.

Information and Communications Technology (ICT) · Seoul$5.7M Series A
Adcentrx Therapeutics
April 2023

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

Biotechnology · San Diego$51.0M Series A

Where Partners Investment invests

Biotechnology10
Medical6
Artificial Intelligence (AI)5
Pharmaceutical4
Health Care4
Information Technology3

About Partners Investment's portfolio

How many companies has Partners Investment invested in?

Partners Investment has invested in 79 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Partners Investment invest in?

Partners Investment's top investment sectors include Biotechnology, Medical, Artificial Intelligence (AI), Pharmaceutical, Health Care. The firm invests across 39 different industry categories.

What is Partners Investment's largest investment?

Among tracked funding rounds, Harbinger Health received $140.0M in a Series B round. Partners Investment's total known invested capital is $926.9M.

What is the average investment size for Partners Investment?

Partners Investment's average investment size is $16.6M across its portfolio of 79 companies.

What are Partners Investment's most recent investments?

Recent Partners Investment portfolio additions include Dime Bio, Artist United, MediThinQ, JLT, Ubix Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 79 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →